CANTARA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 7.101
EU - Europa 6.451
AS - Asia 3.198
SA - Sud America 552
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 206
OC - Oceania 17
Totale 17.789
Nazione #
US - Stati Uniti d'America 6.967
IT - Italia 1.579
RU - Federazione Russa 1.341
GB - Regno Unito 1.143
SG - Singapore 1.070
CN - Cina 964
IE - Irlanda 733
BR - Brasile 444
SE - Svezia 390
VN - Vietnam 330
DE - Germania 293
FR - Francia 281
HK - Hong Kong 240
UA - Ucraina 229
KR - Corea 174
FI - Finlandia 167
IN - India 123
ZA - Sudafrica 118
CA - Canada 70
NL - Olanda 69
BD - Bangladesh 64
ES - Italia 50
TR - Turchia 48
AR - Argentina 43
PL - Polonia 43
JP - Giappone 37
MX - Messico 28
IQ - Iraq 24
BE - Belgio 23
AT - Austria 22
IR - Iran 22
CI - Costa d'Avorio 21
AU - Australia 15
MA - Marocco 14
CH - Svizzera 13
EC - Ecuador 13
EG - Egitto 13
CL - Cile 12
CZ - Repubblica Ceca 12
SA - Arabia Saudita 11
CO - Colombia 10
JO - Giordania 10
KE - Kenya 10
LT - Lituania 10
PK - Pakistan 10
UZ - Uzbekistan 10
VE - Venezuela 10
GR - Grecia 9
ID - Indonesia 9
JM - Giamaica 9
DZ - Algeria 8
NG - Nigeria 8
NP - Nepal 7
PH - Filippine 7
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
RO - Romania 6
CR - Costa Rica 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
IL - Israele 4
KZ - Kazakistan 4
PE - Perù 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
LU - Lussemburgo 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AZ - Azerbaigian 2
BH - Bahrain 2
BS - Bahamas 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IM - Isola di Man 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
BY - Bielorussia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
Totale 17.514
Città #
Southend 996
Dallas 832
Dublin 720
Fairfield 600
Singapore 577
Ashburn 557
Santa Clara 412
Moscow 401
San Jose 367
Milan 362
Chandler 346
Woodbridge 236
Seattle 228
Hong Kong 225
Hefei 219
Wilmington 218
Beijing 214
Council Bluffs 204
Houston 193
Jacksonville 183
Cambridge 176
Florence 172
Siena 171
Seoul 169
Ann Arbor 158
Los Angeles 132
Rome 120
New York 119
The Dalles 119
Ho Chi Minh City 107
Johannesburg 107
Munich 97
Princeton 90
Lauterbourg 89
Helsinki 84
Hanoi 68
Nanjing 53
São Paulo 51
Shanghai 46
Buffalo 44
Columbus 44
San Diego 39
Chicago 38
Poggiomarino 37
Orem 36
Boardman 34
Potenza Picena 33
Warsaw 33
Bengaluru 32
London 32
Turku 32
Montreal 31
Redondo Beach 30
San Mateo 30
Lappeenranta 28
Frankfurt am Main 27
Tokyo 27
Turin 27
Chennai 25
Figino 25
Brooklyn 24
Dearborn 24
Atlanta 23
Abidjan 21
Málaga 21
Brussels 20
Lancaster 20
Naples 19
Stockholm 19
Tianjin 19
Amsterdam 17
Denver 16
Izmir 16
Nanchang 16
San Francisco 16
Fremont 15
Miami 15
Redwood City 15
Toronto 15
Belo Horizonte 14
Boston 14
Guangzhou 14
Haiphong 14
Manchester 14
Nuremberg 14
Portsmouth 14
Washington 14
Da Nang 13
Düsseldorf 13
Kunming 13
Phoenix 13
Ravenna 13
Rio de Janeiro 13
Shenyang 13
Dong Ket 12
Vienna 12
Zurich 12
Clifton 11
Curitiba 11
Jiaxing 11
Totale 11.525
Nome #
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 382
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 358
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 350
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 345
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 333
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 326
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 307
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 301
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 297
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 297
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 293
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 285
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 279
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 276
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 273
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 270
Clinical significance of type 2 iodothyronine deiodinase polymorphism 262
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 249
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 246
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 244
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 243
Gene-related alterations in four male patients with elevated serum gonadotrophins levels 240
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 240
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 234
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 231
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 229
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 228
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 227
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 226
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 223
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 221
BROX haploinsufficiency in familial nonmedullary thyroid cancer 219
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 207
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 207
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 206
Mitigation of UV-B Radiation Stress in Tobacco Pollen by Expression of the Tardigrade Damage Suppressor Protein (Dsup) 206
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 204
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 202
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 202
miRNA Targets: From Prediction Tools to Experimental Validation 202
Silent thyroiditis following vaccination against COVID-19: report of two cases 200
Follow-up after bariatric surgery: is it time to tailor it? Analysis of early predictive factors of 3-year weight loss predictors of unsuccess in bariatric patients 200
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 199
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 199
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 198
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 197
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 196
Proteomics Reveals How the Tardigrade Damage Suppressor Protein Teaches Transfected Human Cells to Survive UV-C Stress 194
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 194
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 192
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 188
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 188
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 188
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 185
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics 181
Telomeres and thyroid cancer 180
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 177
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 175
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 174
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 172
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 170
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 169
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade 165
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 163
Familial non-medullary thyroid cancer: a critical review 163
Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer 160
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium 157
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 155
HLA class I expression on human platelets is highly variable and correlates with distinct allele group frequencies 153
Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2) 153
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 150
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 150
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 149
TAT-BH4 counteracts A beta toxicity on capillary endothelium 139
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 136
PAPPA expression in indeterminate thyroid nodules as screening test to select patients for molecular testing 132
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 127
What's Wrong in a Jump? Prediction and Validation of Splice Site Variants 127
null 126
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology 125
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells 114
The impact of CPT1B rs470117, LEPR rs1137101 and BDNF rs6265 polymorphisms on the risk of developing obesity in an Italian population 101
Sex hormone profiles in patients with Torsades de Pointes ventricular tachycardia 89
Telomerase and the endocrine system. 88
Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update 77
Expression of the ring ligase PRAJA2 in thyroid cancer 73
null 60
null 36
Investigating the Cytoprotective Mechanisms of the Tardigrade Damage Suppressor (Dsup) Protein in Human Cells Under Hypoxic Stress 35
Totale 17.789
Categoria #
all - tutte 56.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022799 0 96 59 86 49 43 36 35 39 88 115 153
2022/20231.302 71 151 151 171 101 259 45 81 141 42 43 46
2023/20241.346 45 43 102 72 90 278 441 66 23 26 48 112
2024/20253.018 87 113 344 271 351 203 89 163 307 162 304 624
2025/20266.911 500 854 640 801 1.188 253 749 254 248 354 339 731
2026/2027538 309 229 0 0 0 0 0 0 0 0 0 0
Totale 17.789